Generate Biomedicines

Provide day-to-day medical oversight for late-stage clinical trials in asthma and COPD to ensure patient safety and data integrity. Collaborate cross-functionally to author regulatory documents and interpret clinical trial data for filings and publications.

Lead clinical science for Phase 2 and 3 respiratory trials, focusing on asthma and COPD. Drive the development of protocols, regulatory documents, and oversee day-to-day study execution and data quality.

The Vice President will lead the Respiratory Product Strategy Team to design and deliver late-stage clinical programs for asthma and COPD. They are responsible for building a high-performing team, overseeing global clinical trials, and managing regulatory interactions and safety profiles.